top of page
Identifying and targeting resistance factors upon immune checkpoint inhibition for better combinatorial treatment strategies leading to improved outcomes
This poster showcases how the Farcastâ„¢ TruTumor HNSCC platform aids in advancing combination therapy discovery to enhance treatment outcomes for patients.
Enter your details to see the full poster now
bottom of page